By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Complete Anxiety Reversal Achieved Through Amygdala Circuit Restoration

Complete Anxiety Reversal Achieved Through Amygdala Circuit Restoration

GMJ
Last updated: 22/06/2026 04:17
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Scientific illustration of amygdala brain circuits involved in anxiety processing
Researchers successfully reversed anxiety in mice by targeting a specific group of amygdala neurons. The breakthrough identifies a promising new target for developing more precise anxiety treatments. — Photo: Robina Weermeijer / Pexels
SHARE
1 min read|132 words

A landmark experimental study demonstrates that complete reversal of anxiety and social deficits can be achieved by restoring normal neural activity in a specific population of amygdala neurons. Researchers utilized advanced neuroscience techniques to characterize this previously unknown neuronal group and its critical role in emotional regulation.

When these neurons functioned abnormally, laboratory mice exhibited classic anxiety behaviors and social withdrawal. Upon restoration of normal circuit activity, anxiety symptoms completely resolved, providing compelling evidence that this neural mechanism represents a key control point for anxiety responses.

This circuit-based finding could revolutionize therapeutic approaches to anxiety disorders, moving toward interventions that target specific neural mechanisms rather than broad neurochemical systems. The precision of this approach suggests potential for improved efficacy and tolerability in future anxiety treatments. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: Scientists Reverse Anxiety in Mice by Targeting Tiny Amygdala Circuit →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
What makes prostate cancer aggressive? Biology, genetics, and clinical grading explained

Prostate cancer aggressiveness is determined by histological grade (Gleason score), genetic mutations…

UK childhood vaccination coverage holds steady at high levels, latest quarterly data shows

The UK's Cover of Vaccination Evaluated Rapidly (COVER) programme reports sustained high…

EMA Launches Email Notifications for Clinical Trial Information System

The European Medicines Agency has rolled out email notification subscriptions in CTIS,…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Global HealthPolicy & Systems

Four Nurses Recover from Ebola in DRC Outbreak, WHO Confirms Full Recovery

By
Prof. Giorgi Pkhakadze
02/06/2026

PHEIC Declaration: Cross-Border Ebola Transmission Confirmed Between DRC and Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Data visualization showing fiber intake mortality benefits across population studies

The Fiber Gap: Americans Halfway to Protective Dose, Missing Life-Saving Benefits

By
Prof. Giorgi Pkhakadze
10/06/2026
Legal scales with world map background representing international migration law framework

What Every Health Professional Should Know About Migrant Legal Protections

By
Prof. Giorgi Pkhakadze
20/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up